Technical Analysis for XNCR - Xencor, Inc.

Grade Last Price % Change Price Change
grade F 34.57 0.23% 0.08
XNCR closed up 0.23 percent on Wednesday, January 16, 2019, on 1.27 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical XNCR trend table...

Date Alert Name Type % Chg
Jan 16 20 DMA Resistance Bearish 0.00%
Jan 16 MACD Bearish Signal Line Cross Bearish 0.00%
Jan 15 20 DMA Resistance Bearish 0.23%
Jan 15 Doji - Bullish? Reversal 0.23%
Jan 15 Down 3 Days in a Row Weakness 0.23%
Jan 15 Down 4 Days in a Row Weakness 0.23%
Jan 14 Fell Below 200 DMA Bearish -0.32%
Jan 14 Fell Below 20 DMA Bearish -0.32%
Jan 14 Fell Below 50 DMA Bearish -0.32%
Jan 14 MACD Bearish Centerline Cross Bearish -0.32%

Older signals for XNCR ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing engineered monoclonal antibodies to treat severe and life-threatening diseases. It develops its antibody product candidates to treat autoimmune and allergic diseases, cancer, and other conditions through XmAb technology platform. The company's engineered antibodies that are in development include XmAb5871, a B-cell inhibitor that is in Phase Ib/IIa clinical trials for the treatment of autoimmune diseases, such as rheumatoid arthritis and lupus; XmAb7195, an IgE inhibitor to treat severe asthma and allergic diseases; and XmAb5574/MOR208, a Cytotoxic B-cell depleting product candidate for the treatment of B-cell cancers. It has a collaboration agreement with Boehringer Ingelheim International GmbH; and development and manufacturing services agreement with Catalent Pharma Solutions LLC. The company was founded in 1997 and is based in Monrovia, California.
Is XNCR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 48.38
52 Week Low 20.16
Average Volume 192,916
200-Day Moving Average 37.2881
50-Day Moving Average 37.3106
20-Day Moving Average 35.2405
10-Day Moving Average 36.475
Average True Range 2.0308
ADX 15.57
+DI 15.8544
-DI 24.2714
Chandelier Exit (Long, 3 ATRs ) 33.2326
Chandelier Exit (Short, 3 ATRs ) 37.3124
Upper Bollinger Band 38.9969
Lower Bollinger Band 31.4841
Percent B (%b) 0.41
BandWidth 21.318653
MACD Line -0.2843
MACD Signal Line -0.2483
MACD Histogram -0.036
Fundamentals Value
Market Cap 1.62 Billion
Num Shares 46.9 Million
EPS -0.87
Price-to-Earnings (P/E) Ratio -39.74
Price-to-Sales 29.06
Price-to-Book 3.08
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 36.69
Resistance 3 (R3) 36.73 36.07 36.33
Resistance 2 (R2) 36.07 35.53 36.05 36.21
Resistance 1 (R1) 35.32 35.20 35.70 35.28 36.10
Pivot Point 34.66 34.66 34.85 34.64 34.66
Support 1 (S1) 33.91 34.12 34.29 33.87 33.04
Support 2 (S2) 33.25 33.79 33.23 32.93
Support 3 (S3) 32.50 33.25 32.81
Support 4 (S4) 32.46